Stock screenerAll disclosures →
EDGAR →
AKTX
Conviction 49HealthcareScan · Mon, Aug 10, 2026Bullish harami
AKTX$7.72+10.29%
ResistanceSupportVol 14Vol MA14 28.5K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price7.72
Change+10.29%
Gap+2.21%
Rel volume0.21×
Avg volume33.51K
Avg $ vol312.12K
SMA 209.11
SMA 5011.41
SMA 2004.31
Price vs 50-32.36%
Price vs 200+79.24%
MA stackmixed
50/200 cross—
Supertrenddown · 10.66
RSI (14)40
MACD hist-0.10
MACD cross—
Stoch %K / %D23 / 13
ADX (14)19
+DI / −DI14 / 22
RSI divergence—
MACD divergenceBullish
ATR %+15.93%
ADR %11.58%
52w high22.05
52w low0.1210
From 52w high-64.99%
Above 52w low+6280.17%
New 52w highNo
SqueezeOff
Bollinger width75.44%
%B0.30
Donchian pos10.75%
Donchian high13.70
Donchian low7.00
AVWAP (52w high)15.63
vs AVWAP high-50.61%
AVWAP (52w low)13.61
vs AVWAP low-43.27%
OBV trendDown
Chaikin MF (20)-0.43
Today vs 20d0.21×
Avg vol (14d)28.5K
Avg vol (20d)33.51K
Avg $ vol (20d)312.12K
Market cap706.9B
RS 3m (vs SPY)+0.69%
RS 6m (vs SPY)+2997.00%
RS line new highNo
Trend template6/8
Technical rank64.4
1 week+4.89%
1 month-44.38%
3 months+23.52%
6 months+3185.11%
1 year+664.36%
YTD+2562.07%
P/E—
P/B—
P/S—
P/FCF—
EPS0.0000
Div yield—
ROE-120.29%
ROA-51.04%
Debt/Eq0.01
Current0.27
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth12.60%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value706.89B
Revenue—
Net income-14.46M
Gross profit—
Free cash flow-10.58M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees5
ListedFri, Dec 7, 2012
Free float1.94M
Float %0.0%
Short interest16.43K
Days to cover0.2d
Short volume61.5%
Squeeze score17 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction49 / 100
Pattern quality—
Tech rank64.4 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Breaking out nowJun 5 – Jun 162 scans
- Broke outJul 71 scan
Congress activity
Disclosed STOCK Act trades in AKTX
No recent disclosed trades by Congress in AKTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AKTX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Farag Kameel D. Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-07-16 | Grant | 1.13K | $13K | 2026-07-16 | 2026-08-05 |
Patel Samir Rashmikant Director · American Depositary Shares representing Ordinary Shares · 2026-07-07 | Exercise | 1.21K | $10K | 2026-07-07 | 2026-07-17 |
Patel Samir Rashmikant Director · American Depositary Shares representing Ordinary Shares · 2026-07-07 | Exercise | 15.47K | $6 | 2026-07-07 | 2026-07-17 |
Patel Samir Rashmikant Director · American Depositary Shares representing Ordinary Shares · 2026-07-07 | Exercise | 5.8K | $2 | 2026-07-07 | 2026-07-17 |
Patel Samir Rashmikant Director · Pre-Funded Warrant to purchase American Depositary Shares · 2026-07-07 | Exercise | 1.21K | $39K | 2026-07-07 | 2026-07-17 |
Patel Samir Rashmikant Director · Pre-Funded Warrant to purchase ADSs · 2026-07-07 | Exercise | 15.47K | $250K | 2026-07-07 | 2026-07-17 |
Patel Samir Rashmikant Director · Pre-Funded Warrant to purchase ADSs · 2026-07-07 | Exercise | 5.8K | $94K | 2026-07-07 | 2026-07-17 |
Gaslightwala Abizer CEO · Stock Option (Right to Buy) · 2026-06-24 | Grant | 5.5K | — | 2026-06-24 | 2026-06-25 |
Gaslightwala Abizer CEO · Stock Option (Right to Buy) · 2026-06-24 | Grant | 15.56K | — | 2026-06-24 | 2026-06-25 |
Farag Kameel D. Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-06-24 | Grant | 1.25K | $13K | 2026-06-24 | 2026-06-25 |
SEC filings
EDGAR filings in AKTX · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.